Exact Mass: 166.0504

Exact Mass Matches: 166.0504

Found 186 metabolites which its exact mass value is equals to given mass value 166.0504, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-Methylxanthine

2-hydroxy-1-methyl-6,9-dihydro-1H-purin-6-one

C6H6N4O2 (166.0491)


1-Methylxanthine is one of the major metabolites of caffeine in humans. The oxidation of 1-methylxanthine to 1-methyluric acid occurs so rapidly that the parent compound could not be detected in plasma, and only low concentrations could be detected in the brain (PMID: 28863020). 1-methylxanthine is the major metabolites of caffeine in the human. The oxidation of 1-methylxanthine to 1-methyluric acid occurred so rapidly that the parent compound could not be detected in plasma, and only low concentrations could be detected in brain. (PMID: 28863020 [HMDB] 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2]. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2].

   

3-Methylxanthine

3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


3-methyl-9H-xanthine is a 3-methylxanthine tautomer where the imidazole proton is located at the 9-position. It has a role as a metabolite. It is a tautomer of a 3-methyl-7H-xanthine. 3-Methylxanthine, also known as 3 MX or purine analog, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 3-Methylxanthine is a caffeine and a theophylline metabolite. (PMID 16870158, 16678550) 3-Methylxanthine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1076-22-8 (retrieved 2024-07-02) (CAS RN: 1076-22-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle.

   

Ethionamide

2-ethylpyridine-4-carbothioamide

C8H10N2S (166.0565)


Ethionamide is only found in individuals that have used or taken this drug. It is a second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)Ethionamide may be bacteriostatic or bactericidal in action, depending on the concentration of the drug attained at the site of infection and the susceptibility of the infecting organism. Ethionamide, like prothionamide and pyrazinamide, is a nicotinic acid derivative related to isoniazid. It is thought that ethionamide undergoes intracellular modification and acts in a similar fashion to isoniazid. Isoniazid inhibits the synthesis of mycoloic acids, an essential component of the bacterial cell wall. Specifically isoniazid inhibits InhA, the enoyl reductase from Mycobacterium tuberculosis, by forming a covalent adduct with the NAD cofactor. It is the INH-NAD adduct that acts as a slow, tight-binding competitive inhibitor of InhA. Ethionamide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=536-33-4 (retrieved 2024-07-12) (CAS RN: 536-33-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Ethionamide (2-ethylthioisonicotinamide) is a second-line anti-tuberculosis antibiotic.

   

D-Xylonic acid

(2R,3S,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


D-​Xylonic acid belongs to the family of hydroxy fatty acids. These are fatty acids in which the chain bears an hydroxyl group. ​D-​Xylonic acid has been identified in the human placenta (PMID: 32033212).

   

Arabonate/xylonate

(2S,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


Arabinonic acid (CAS: 13752-83-5) is a substrate of L-arabinonate dehydratase [EC 4.2.1.25] in the pathway ascorbate and aldarate metabolism (KEGG). Arabinonic acid is a substrate of L-arabinonate dehydratase [EC 4.2.1.25] in pathway ascorbate and aldarate metabolism. (KEGG) [HMDB]

   

Ribonic acid

(2R,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


Ribonic acid (CAS: 17812-24-7) is a product of the enzyme ribose 1-dehydrogenase (NADP+) [EC 1.1.1.115] (KEGG). Ribonic acid is a product of the enzyme ribose 1-dehydrogenase (NADP+) [EC 1.1.1.115] (KEGG). [HMDB]

   

7-Methylxanthine

7-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


7-Methylxanthine is a methyl derivative of xanthine, found occasionally in human urine. 7-Methylxanthine is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites, including 7-methylxanthine. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID:11712316, 15833286, 3506820, 15013152). Found in sugar cane and other biol. sources, a urinary metabolite of caffeine in man 7-Methylxanthine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=552-62-5 (retrieved 2024-07-16) (CAS RN: 552-62-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 7-Methylxanthine, a methyl derivative of xanthine, is one of the purine components in urinary calculi.

   

L-Lyxonic acid

(2R,3R,4S)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


L-​Lyxonic acid belongs to the family of sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.

   

L-Xylonic acid

(2S,3R,4S)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


L-Xylonic acid belongs to the family of sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.

   

L-Arabinonate

2R,3S,4S,5-tetraydroxy-pentanoic acid

C5H10O6 (166.0477)


   

D-apionate

D-apionate

C5H10O6 (166.0477)


   

S-Propyl 1-propanesulfinothioate

1-Propanesulphinothioic acid, S-propyl ester

C6H14OS2 (166.0486)


S-Propyl 1-propanesulfinothioate is found in onion-family vegetables. S-Propyl 1-propanesulfinothioate is isolated from onions, garlic and other allium Isolated from onions, garlic and other alliums. S-Propyl 1-propanesulfinothioate is found in onion-family vegetables.

   

Noradrenochrome o-semiquinone

(3,6-dihydroxy-2,3-dihydro-1H-indol-5-yl)oxidanyl

C8H8NO3 (166.0504)


Noradrenochrome o-semiquinone is a intermediate metabolite in the reduction of noradrenochrome. Noradrenochrome is an aminochrome and is closely related to adrenochrome and dopaminochrome. This compound is present in human brain, induces a combination of neurotoxic and mind-mood altering effect, and is therapeutic for the treatment of schizophrenia. noradrenochrome o-semiquinone is a intermediate metabolite in the reduction of noradrenochrome

   

9-Methylxanthine

9-methyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


9-Methylxanthine is a diuretic agent that serves as a smooth muscle relexant and cardiac muscle and CNS stimulant. Clinically, it is employed as a bronchodilator. 9-Methylxanthine is found to be effective in treating apnea in preterm infants (PMID: 11686952). In another study, 9-Methylxanthine, as a chemical relatives of caffeine, is able to evoke contractures in mammalian heart. (PMID: 1226453)

   

Xylan

(2R,3R,5S,6S)-tetrahydropyran-2,3,4,5,6-pentol

C5H10O6 (166.0477)


Xylan is a group of hemicelluloses, representing the third most abundant biopolymer on Earth. It is found in plants, in the secondary cell walls of dicotyledonous plants and in all cell walls of grasses (monocotyledonous). Xylans are polysaccharides made up of β-1,4-linked xylose (a pentose sugar) residues with side branches of α-arabinofuranose and α-glucuronic acids and contribute to cross-linking of cellulose microfibrils and lignin through ferulic acid residues. On the basis of the substituting groups, xylan can be categorized into three classes i) glucuronoxylan (GX) ii) neutral arabinoxylan (AX) and iii) glucuronoarabinoxylan (GAX). The quality of cereal flours and the hardness of dough are largely affected by the amount of xylan. Xylan is one of the foremost anti-nutritional factors in commonly used feedstuff raw materials. It is a major component of plant secondary cell walls which is a major source of renewable energy especially for second generation biofuels. However, since microorganisms like yeast cannot ferment pentoses naturally, xylose (the pentose backbone of xylan) results hard to ferment in biofuel production, reducing its use in renewable energy production (PMID: 18299887, PMID: 31077637). Occurs in all land plants, component of dietary roughage

   

Carpasemine

N-Benzylcarbamimidothioate

C8H10N2S (166.0565)


Carpasemine, also known as 1-benzylthiourea or benzylthiouronium chloride, belongs to benzene and substituted derivatives class of compounds. Those are aromatic compounds containing one monocyclic ring system consisting of benzene. Carpasemine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Carpasemine can be found in papaya, which makes carpasemine a potential biomarker for the consumption of this food product.

   

D-Xylonic acid

D-Arabonic acid

C5H10O6 (166.0477)


   

7-methyl-7,9-dihydro-1H-purine-6,8-dione

7-methyl-7,9-dihydro-1H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

9-methyl-7,9-dihydro-1H-purine-6,8-dione

9-methyl-7,9-dihydro-1H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

1-Me-6,8-Purinediol

1-Me-6,8-Purinediol

C6H6N4O2 (166.0491)


   

Benzylthiourea

Thiourea,N-(phenylmethyl)-

C8H10N2S (166.0565)


   

3-methyl-7,9-dihydro-3H-purine-6,8-dione

3-methyl-7,9-dihydro-3H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

SCHEMBL12017370

SCHEMBL12017370

C5H10O6 (166.0477)


   

3-Methylxanthine

3-Methylxanthine

C6H6N4O2 (166.0491)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; GMSNIKWWOQHZGF-UHFFFAOYSA-N_STSL_0034_3-Methylxanthine_0500fmol_180410_S2_LC02_MS02_57; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle.

   

7-Methylxanthine

7-Methylxanthine

C6H6N4O2 (166.0491)


An oxopurine that is xanthine in which the hydrogen attached to the nitrogen at position 7 is replaced by a methyl group. It is an intermediate metabolite in the synthesis of caffeine. 7-Methylxanthine, a methyl derivative of xanthine, is one of the purine components in urinary calculi.

   

1-Methylxanthine

1-Methylxanthine

C6H6N4O2 (166.0491)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; MVOYJPOZRLFTCP-UHFFFAOYSA-N_STSL_0033_1-Methylxanthine_0500fmol_180410_S2_LC02_MS02_41; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2]. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2].

   

Allicin + 4H (not validated)

Allicin + 4H (not validated)

C6H14OS2 (166.0486)


Annotation level-3

   

4-Fluorocinnamic acid; LC-tDDA; CE10

4-Fluorocinnamic acid; LC-tDDA; CE10

C9H7FO2 (166.043)


   

4-Fluorocinnamic acid; LC-tDDA; CE20

4-Fluorocinnamic acid; LC-tDDA; CE20

C9H7FO2 (166.043)


   

4-Fluorocinnamic acid; LC-tDDA; CE30

4-Fluorocinnamic acid; LC-tDDA; CE30

C9H7FO2 (166.043)


   

4-Fluorocinnamic acid; LC-tDDA; CE40

4-Fluorocinnamic acid; LC-tDDA; CE40

C9H7FO2 (166.043)


   

1-Methylxanthine; LC-tDDA; CE10

1-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE20

1-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE30

1-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE40

1-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE10

3-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE20

3-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE30

3-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE40

3-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE10

9-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE20

9-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE30

9-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE40

9-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE10

7-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE20

7-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE30

7-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE40

7-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE0; CorrDec

9-Methylxanthine; AIF; CE0; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE10; CorrDec

9-Methylxanthine; AIF; CE10; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE30; CorrDec

9-Methylxanthine; AIF; CE30; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE0; MS2Dec

9-Methylxanthine; AIF; CE0; MS2Dec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE10; MS2Dec

9-Methylxanthine; AIF; CE10; MS2Dec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE30; MS2Dec

9-Methylxanthine; AIF; CE30; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE0; CorrDec

7-Methylxanthine; AIF; CE0; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE10; CorrDec

7-Methylxanthine; AIF; CE10; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE30; CorrDec

7-Methylxanthine; AIF; CE30; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE0; MS2Dec

7-Methylxanthine; AIF; CE0; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE10; MS2Dec

7-Methylxanthine; AIF; CE10; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE30; MS2Dec

7-Methylxanthine; AIF; CE30; MS2Dec

C6H6N4O2 (166.0491)


   

Apionic acid

2,3,4,4-tetrahydroxy-pentanoic acid

C5H10O6 (166.0477)


   

O-Benzoylthiamine

1-Propanesulfinothioic acid, S-propyl ester

C6H14OS2 (166.0486)


   

9-Methylxanthine

9-methyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


   

1H-Imidazole-5-carboxylicacid,2-amino-4-cyano-1-methyl-(9CI)

1H-Imidazole-5-carboxylicacid,2-amino-4-cyano-1-methyl-(9CI)

C6H6N4O2 (166.0491)


   

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-1-methyl-(9CI)

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-1-methyl-(9CI)

C6H6N4O2 (166.0491)


   

8-fluorochroman-4-one

8-fluorochroman-4-one

C9H7FO2 (166.043)


   

5-Fluoro-2-hydroxymethylbenzimidazole

5-Fluoro-2-hydroxymethylbenzimidazole

C8H7FN2O (166.0542)


   

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-,methylester(9CI)

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-,methylester(9CI)

C6H6N4O2 (166.0491)


   

1-(2-Methylphenyl)thiourea

1-(2-Methylphenyl)thiourea

C8H10N2S (166.0565)


   

m-Tolyl-thiourea

m-Tolyl-thiourea

C8H10N2S (166.0565)


   

DIMETHYLDITHIOCARBAMIC ACID with DIMETHYLAMINE (1:1)

DIMETHYLDITHIOCARBAMIC ACID with DIMETHYLAMINE (1:1)

C5H14N2S2 (166.0598)


   

pyrazine-2,5-dicarboxamide

pyrazine-2,5-dicarboxamide

C6H6N4O2 (166.0491)


   

4-(3-Chlorophenyl)but-1-ene

4-(3-Chlorophenyl)but-1-ene

C10H11Cl (166.0549)


   

1-but-3-enyl-4-chlorobenzene

1-but-3-enyl-4-chlorobenzene

C10H11Cl (166.0549)


   

4-Fluorocinnamic Acid

4-Fluorocinnamic Acid

C9H7FO2 (166.043)


   

3-(4-Chloro-3-methylphenyl)prop-1-ene

3-(4-Chloro-3-methylphenyl)prop-1-ene

C10H11Cl (166.0549)


   

4-ALLYLSULFANYL-PHENOL

4-ALLYLSULFANYL-PHENOL

C9H10OS (166.0452)


   

4-AMINO-6-FLUOROISOINDOLIN-1-ONE

4-AMINO-6-FLUOROISOINDOLIN-1-ONE

C8H7FN2O (166.0542)


   

3-Carboxyphenylboronic acid

3-Carboxyphenylboronic acid

C7H7BO4 (166.0437)


   

2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONICACID

2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONICACID

C10H11Cl (166.0549)


   

2-methoxy-1,3-bis(methylsulfanyl)propane

2-methoxy-1,3-bis(methylsulfanyl)propane

C6H14OS2 (166.0486)


   

3-(2-Fluorophenyl)acrylic acid

3-(2-Fluorophenyl)acrylic acid

C9H7FO2 (166.043)


   

3-Chloropropyl Dimethyl Methoxysilane

3-Chloropropyl Dimethyl Methoxysilane

C6H15ClOSi (166.0581)


   

2-Carboxyphenylboronic acid

2-Carboxyphenylboronic acid

C7H7BO4 (166.0437)


   

benzo[d][1,3]dioxol-4-ylboronic acid

benzo[d][1,3]dioxol-4-ylboronic acid

C7H7BO4 (166.0437)


   

Benzaldehyde,3-acetyl-4-fluoro-

Benzaldehyde,3-acetyl-4-fluoro-

C9H7FO2 (166.043)


   

8-FLUOROISOCHROMAN-4-ONE

8-FLUOROISOCHROMAN-4-ONE

C9H7FO2 (166.043)


   

4-(1,3-thiazolan-2-yl)pyridine

4-(1,3-thiazolan-2-yl)pyridine

C8H10N2S (166.0565)


   

1-(2-(METHYLTHIO)PHENYL)ETHANONE

1-(2-(METHYLTHIO)PHENYL)ETHANONE

C9H10OS (166.0452)


   

6-(Aminomethyl)-3-morpholinone hydrochloride

6-(Aminomethyl)-3-morpholinone hydrochloride

C5H11ClN2O2 (166.0509)


   

2-Chloro-1-phenyl-2-butene

2-Chloro-1-phenyl-2-butene

C10H11Cl (166.0549)


   

ammonium diethyldithiocarbamate

ammonium diethyldithiocarbamate

C5H14N2S2 (166.0598)


   

6,8-DIFLUORO-1,2-DIHYDRO-NAPHTHALENE

6,8-DIFLUORO-1,2-DIHYDRO-NAPHTHALENE

C10H8F2 (166.0594)


   

(6-Carbamoylpyridin-3-yl)boronic acid

(6-Carbamoylpyridin-3-yl)boronic acid

C6H7BN2O3 (166.055)


   

L-Ribonic acid

L-(+)-Ribonic acid

C5H10O6 (166.0477)


A ribonic acid having L-configuration.

   

3-(2-Chlorophenyl)-2-methylprop-1-ene

3-(2-Chlorophenyl)-2-methylprop-1-ene

C10H11Cl (166.0549)


   

3-(3-Chlorophenyl)-2-methylprop-1-ene

3-(3-Chlorophenyl)-2-methylprop-1-ene

C10H11Cl (166.0549)


   

1-chloro-4-(2-methylallyl)benzene

1-chloro-4-(2-methylallyl)benzene

C10H11Cl (166.0549)


   

6-Fluoro-4-chromanone

6-Fluoro-4-chromanone

C9H7FO2 (166.043)


   

5-FLUORO-2,3-DIHYDROBENZOFURAN-7-CARBOXALDEHYDE

5-FLUORO-2,3-DIHYDROBENZOFURAN-7-CARBOXALDEHYDE

C9H7FO2 (166.043)


   

6-Fluoro-4-methoxy-1H-indazole

6-Fluoro-4-methoxy-1H-indazole

C8H7FN2O (166.0542)


   

4-Fluoro-6-methoxy-1H-indazole

4-Fluoro-6-methoxy-1H-indazole

C8H7FN2O (166.0542)


   

2,3-pyrazinedicarboxamide

2,3-pyrazinedicarboxamide

C6H6N4O2 (166.0491)


   

(5-Fluoro-1H-indazol-3-yl)methanol

(5-Fluoro-1H-indazol-3-yl)methanol

C8H7FN2O (166.0542)


   

6H-Purin-6-one,2,8-diamino-1,9-dihydro-

6H-Purin-6-one,2,8-diamino-1,9-dihydro-

C5H6N6O (166.0603)


   

S-(2-methylphenyl) ethanethioate

S-(2-methylphenyl) ethanethioate

C9H10OS (166.0452)


   

1,3-Benzodioxol-5-ylboronic acid

1,3-Benzodioxol-5-ylboronic acid

C7H7BO4 (166.0437)


   

(METHYLTHIO)(MORPHOLIN-4-YL)METHYLENE]MALONONITRILE

(METHYLTHIO)(MORPHOLIN-4-YL)METHYLENE]MALONONITRILE

C9H11OP (166.0547)


   

6-Fluoroimidazo[1,2-a]pyridine-2-methanol

6-Fluoroimidazo[1,2-a]pyridine-2-methanol

C8H7FN2O (166.0542)


   

1-Chloro-1,2,3,4-tetrahydronaphthalene

1-Chloro-1,2,3,4-tetrahydronaphthalene

C10H11Cl (166.0549)


   

3-Aminopyrrolidine-3-carboxylic acid hydrochloride

3-Aminopyrrolidine-3-carboxylic acid hydrochloride

C5H11ClN2O2 (166.0509)


   

2-(2-THIAZOLIDINYL)PYRIDINE

2-(2-THIAZOLIDINYL)PYRIDINE

C8H10N2S (166.0565)


   

1H-Imidazo[1,2-b]pyrazole-6-carboxylicacid,7-amino-(9CI)

1H-Imidazo[1,2-b]pyrazole-6-carboxylicacid,7-amino-(9CI)

C6H6N4O2 (166.0491)


   

2-dimethyl(chloromethyl)silyloxypropane

2-dimethyl(chloromethyl)silyloxypropane

C6H15ClOSi (166.0581)


   

(3-FLUOROSTYRYL)BORONIC ACID

(3-FLUOROSTYRYL)BORONIC ACID

C8H8BFO2 (166.0601)


   

4-(ETHYLTHIO)BENZALDEHYDE

4-(ETHYLTHIO)BENZALDEHYDE

C9H10OS (166.0452)


   

trans-2-(4-fluorophenyl)vinylboronic acid

trans-2-(4-fluorophenyl)vinylboronic acid

C8H8BFO2 (166.0601)


   

4-Morpholinesulfonamide

4-Morpholinesulfonamide

C4H10N2O3S (166.0412)


   

6-FLUOROCHROMAN-3-ONE

6-FLUOROCHROMAN-3-ONE

C9H7FO2 (166.043)


   

N-methylbenzenecarbothiohydrazide

N-methylbenzenecarbothiohydrazide

C8H10N2S (166.0565)


   

ethyl 2,2-difluoroacetoacetate

ethyl 2,2-difluoroacetoacetate

C6H8F2O3 (166.0441)


   

(2E)-3-(3-Fluorophenyl)acrylic acid

(2E)-3-(3-Fluorophenyl)acrylic acid

C9H7FO2 (166.043)


   

1H-Purine-2,6-dione,3,9-dihydro-8-methyl-

1H-Purine-2,6-dione,3,9-dihydro-8-methyl-

C6H6N4O2 (166.0491)


   

6-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

6-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

C6H6N4O2 (166.0491)


   

7-Amino-5-fluoroindolin-2-one

7-Amino-5-fluoroindolin-2-one

C8H7FN2O (166.0542)


   

1-Methyl-1-phenylthiourea

1-Methyl-1-phenyl-thiourea

C8H10N2S (166.0565)


   

1-Methyl-3-phenyl-2-thiourea

1-Methyl-3-phenyl-2-thiourea

C8H10N2S (166.0565)


   

[2-(Chloromethoxy)ethyl](trimethyl)silane

[2-(Chloromethoxy)ethyl](trimethyl)silane

C6H15ClOSi (166.0581)


   

6-AMINO-4-FLUOROISOINDOLIN-1-ONE

6-AMINO-4-FLUOROISOINDOLIN-1-ONE

C8H7FN2O (166.0542)


   

Ethyl 4,4-difluoro-3-oxobutanoate

Ethyl 4,4-difluoro-3-oxobutanoate

C6H8F2O3 (166.0441)


   

p-Boronobenzoic acid

4-Carboxyphenylboronic acid

C7H7BO4 (166.0437)


   

2-Cyano-2-cyclopentylideneethanethioamide

2-Cyano-2-cyclopentylideneethanethioamide

C8H10N2S (166.0565)


   

1,1,3,3-tetramethyldisiloxane-1,3-diol

1,1,3,3-tetramethyldisiloxane-1,3-diol

C4H14O3Si2 (166.0481)


   

2-Propanone,1-(phenylthio)-

2-Propanone,1-(phenylthio)-

C9H10OS (166.0452)


   

6-FLUORO-3-METHYLBENZO[D]ISOXAZOL-5-AMINE

6-FLUORO-3-METHYLBENZO[D]ISOXAZOL-5-AMINE

C8H7FN2O (166.0542)


   

2-(4-Fluorophenyl)malondialdehyde

2-(4-Fluorophenyl)malondialdehyde

C9H7FO2 (166.043)


   

((CHLOROMETHYL)PHENYLETHYL)DIMETHYLCHLOROSILANE

((CHLOROMETHYL)PHENYLETHYL)DIMETHYLCHLOROSILANE

C10H11Cl (166.0549)


   

3-METHYL-6,7-DIHYDROBENZO[B]THIOPHEN-4(5H)-ONE

3-METHYL-6,7-DIHYDROBENZO[B]THIOPHEN-4(5H)-ONE

C9H10OS (166.0452)


   

6-AMINO-7-FLUOROISOINDOLIN-1-ONE

6-AMINO-7-FLUOROISOINDOLIN-1-ONE

C8H7FN2O (166.0542)


   

6,8-Difluoro-1,2-dihydronaphthalene

6,8-Difluoro-1,2-dihydronaphthalene

C10H8F2 (166.0594)


   

3-methyl-7H-purine-2,6-dione

3-methyl-7H-purine-2,6-dione

C6H6N4O2 (166.0491)


   

3-phenylthio-1,2-epoxypropane

3-phenylthio-1,2-epoxypropane

C9H10OS (166.0452)


   

ALLYL PHENYL SULFOXIDE

ALLYL PHENYL SULFOXIDE

C9H10OS (166.0452)


   

4-(Methylthio)acetophenone

4-(Methylthio)acetophenone

C9H10OS (166.0452)


   

1H-1,2,4-Triazole-3-carboxylicacid, 1-(cyanomethyl)-, methyl ester

1H-1,2,4-Triazole-3-carboxylicacid, 1-(cyanomethyl)-, methyl ester

C6H6N4O2 (166.0491)


   

3-Amino-3-imino propanoic acid ethyl ester hydrochloride

3-Amino-3-imino propanoic acid ethyl ester hydrochloride

C5H11ClN2O2 (166.0509)


   

1-(4-Methylphenyl)thiourea

1-(4-Methylphenyl)thiourea

C8H10N2S (166.0565)


   

7-FLUOROCHROMAN-3-ONE

7-FLUOROCHROMAN-3-ONE

C9H7FO2 (166.043)


   

5-Fluoro-4-chromanone

5-Fluoro-4-chromanone

C9H7FO2 (166.043)


   

L-ALLYLGLYCINE

L-ALLYLGLYCINE

C6H8F2O3 (166.0441)


   

1H-Imidazole-1-aceticacid,4-amino-5-cyano-(9CI)

1H-Imidazole-1-aceticacid,4-amino-5-cyano-(9CI)

C6H6N4O2 (166.0491)


   

Butanoic acid,3,3-difluoro-2-oxo-,ethyl ester

Butanoic acid,3,3-difluoro-2-oxo-,ethyl ester

C6H8F2O3 (166.0441)


   

trimethyl(methylsulfonylmethyl)silane

trimethyl(methylsulfonylmethyl)silane

C5H14O2SSi (166.0484)


   

7-fluoro-4-chromanone

7-fluoro-4-chromanone

C9H7FO2 (166.043)


   

2-Propenoic acid,2-fluoro-3-phenyl-

2-Propenoic acid,2-fluoro-3-phenyl-

C9H7FO2 (166.043)


   

4-fluoro-7-hydroxy-2,3-dihydro-1H-inden-1-one

4-fluoro-7-hydroxy-2,3-dihydro-1H-inden-1-one

C9H7FO2 (166.043)


   

8H-Purin-8-one,2,6-diamino-7,9-dihydro-

8H-Purin-8-one,2,6-diamino-7,9-dihydro-

C5H6N6O (166.0603)


   

Benzylthioacetate

Benzylthioacetate

C9H10OS (166.0452)


   

2-amino-4-ethyl-5-methylthiophene-3-carbonitrile

2-amino-4-ethyl-5-methylthiophene-3-carbonitrile

C8H10N2S (166.0565)


   

1H-Indene,5-(chloromethyl)-2,3-dihydro-

1H-Indene,5-(chloromethyl)-2,3-dihydro-

C10H11Cl (166.0549)


   

1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione

1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione

C6H6N4O2 (166.0491)


   

ALPHA-FLUOROCINNAMIC ACID

ALPHA-FLUOROCINNAMIC ACID

C9H7FO2 (166.043)


   

2-Amino-N6-hydroxyadenine

2-Amino-N6-hydroxyadenine

C5H6N6O (166.0603)


D009676 - Noxae > D009153 - Mutagens

   

7,8-Dihydro-2,4(1H,3H)-pteridinedione

7,8-Dihydro-2,4(1H,3H)-pteridinedione

C6H6N4O2 (166.0491)


   

Lyxonic acid

Lyxonic acid

C5H10O6 (166.0477)


   

3-amino-1H-pyrazolo[4,3-c]pyridine-4,6-diol

3-amino-1H-pyrazolo[4,3-c]pyridine-4,6-diol

C6H6N4O2 (166.0491)


   

8-Methyl-9-oxoguanine

8-Methyl-9-oxoguanine

C6H6N4O2 (166.0491)


   

arabic acid

(2S,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


   

3-Hydroxy-4-methylanthranilate

3-Hydroxy-4-methylanthranilate

C8H8NO3- (166.0504)


The conjugate base of 3-hydroxy-4-methylanthranilic acid.

   

4-Amino-3-methoxybenzoate

4-Amino-3-methoxybenzoate

C8H8NO3- (166.0504)


   

2,3,4-Trihydroxy-3-(hydroxymethyl)butanoic acid

2,3,4-Trihydroxy-3-(hydroxymethyl)butanoic acid

C5H10O6 (166.0477)


   

3-Methoxyanthranilate

3-Methoxyanthranilate

C8H8NO3- (166.0504)


An aminobenzoate that results from the removal of a proton from the carboxylic acid group of 3-methoxyanthranilic acid.

   

2-Butene, 3-chloro-1-phenyl-, (Z)-

2-Butene, 3-chloro-1-phenyl-, (Z)-

C10H11Cl (166.0549)


   

ethionamide

ethionamide

C8H10N2S (166.0565)


J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AD - Thiocarbamide derivatives D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Ethionamide (2-ethylthioisonicotinamide) is a second-line anti-tuberculosis antibiotic.

   

Ribonic acid

D-Ribonic acid

C5H10O6 (166.0477)


The D-enantiomer ribonic acid.

   

L-Xylonic acid

L-Xylonic acid

C5H10O6 (166.0477)


   

L-arabinonic acid

L-arabinonic acid

C5H10O6 (166.0477)


   

L-Lyxonic acid

L-Lyxonic acid

C5H10O6 (166.0477)


A lyxonic acid that has L-configuration.

   

D-lyxonic acid

D-lyxonic acid

C5H10O6 (166.0477)


A lyxonic acid that has D-configuration.

   

S-propyl propanethiosulfinate

S-propyl propanethiosulfinate

C6H14OS2 (166.0486)


A sulfinic acid derivative obtained by formal condensation of propanethiosulfinic acid with propanethiol.

   

3-methyl-9H-xanthine

3-methyl-9H-xanthine

C6H6N4O2 (166.0491)


A 3-methylxanthine tautomer where the imidazole proton is located at the 9-position.

   

3-methyl-7H-xanthine

3-methyl-7H-xanthine

C6H6N4O2 (166.0491)


A 3-methylxanthine tautomer where the imidazole proton is located at the 7-position.

   

1-methyl-7H-xanthine

1-methyl-7H-xanthine

C6H6N4O2 (166.0491)


A 1-methylxanthine tautomer where the imidazole proton is located at the 7-position.

   

D-Ribulose

D-Ribulose

C5H10O6 (166.0477)


   

Arabinonic acid/Xylonic acid

Arabinonic acid/Xylonic acid

C5H10O6 (166.0477)


   

n-benzylcarbamimidothioic acid

n-benzylcarbamimidothioic acid

C8H10N2S (166.0565)


   

1-{[(s)-propane-1-sulfinyl]sulfanyl}propane

1-{[(s)-propane-1-sulfinyl]sulfanyl}propane

C6H14OS2 (166.0486)